Copay help by condition · Cancer and blood cancer · read 2026-11-10
Gastrointestinal stromal tumor (GIST): which charitable copay funds are open
1 fund for Gastrointestinal stromal tumor says it is open right now, of the 3 we hold (read 2026-11-10).
Open: Gastrointestinal Stromal Tumors from Accessia Health. Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Gastrointestinal stromal tumor
- OpenGastrointestinal Stromal Tumors
Accessia Health ·
Award level: not statedInsurance supported: not stated
The program page lists the program as Open. Its tracks: publicly insured track open. It shows no date. Source page
- Closed or at capacityGastrointestinal Stromal Tumor (GIST)
CancerCare ·
Award level: not statedInsurance supported: not stated
The page marks the fund as created: approved by the Board of Directors, with CancerCare seeking donations to open it, so it is not taking applications (the fund row's own data-statuses attribute reads created). Source page
- Closed or at capacityGastrointestinal stromal tumors (GIST)
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $4,200Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Closed. Source page
Drugs whose FDA label names Gastrointestinal stromal tumor
2 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 1 has a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Stivarga Regorafenib Every route for this drug | Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Label on openFDA, read 2026-11-10 | Bayer US Patient Assistance Foundation (program page) | not in the CMS negotiated-price file |
| Ayvakit Avapritinib | Gastrointestinal Stromal Tumor (GIST) the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including ... Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Funds for costs around Gastrointestinal stromal tumor
These pay for a kind of cost, not a diagnosis. Each is shown with its own status.
Funds for costs around cancer and blood cancer in general: behavioral health (1 open of 2), caregiver support (0 open of 2), clinical trial costs (0 open of 1), home care (1 open of 1), named fund (0 open of 1), pain management (0 open of 1), testing (1 open of 1) and transportation (0 open of 1). Every one is listed, with its source, on the Cancer and blood cancer page.
Related conditions
No broader or more specific condition page for this one.
Group: Cancer and blood cancer. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-10. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: gastrointestinal-stromal-tumor.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Gastrointestinal stromal tumor?
As read on 2026-11-10, 1 of the 3 funds we hold for Gastrointestinal stromal tumor say they are open: Gastrointestinal Stromal Tumors from Accessia Health. Funds open and close, so check the source page before you apply.
Which organizations run funds for Gastrointestinal stromal tumor?
Accessia Health, CancerCare and TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-10). We do not promise a fund is still in that state today.